Durvalumab and PET-directed CRT after induction FOLFOX for esophageal adenocarcinoma.
Geoffrey Ku • 21 Jan 2021
Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Keep up to date with all the latest news with our monthly newsletter